Viewing StudyNCT00442845



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00442845
Status: COMPLETED
Last Update Posted: 2021-02-18
First Post: 2007-02-28

Brief Title: Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets ACTFAST
Sponsor: Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-01
Start Date Type: None
Primary Completion Date: 2004-02
Primary Completion Date Type: ACTUAL
Completion Date: 2004-02
Completion Date Type: ACTUAL
First Submit Date: 2007-02-28
First Submit QC Date: February 28 2007
Study First Post Date: 2007-03-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-02-17
Last Update Post Date: 2021-02-18
Last Update Post Date Type: ACTUAL